Fig. 1 · Structure

Documents & Downloads

Ruzasvir

HCV NS5A Inhibitor

Ruzasvir is a highly potent inhibitor targeting the nonstructural protein 5A (NS5A) of Hepatitis C Virus (HCV). It effectively disrupts the replication of various NS5A mutants across genotypes GT1a, GT2b, GT3a, and GT4a, with an effective concentration (EC90) ranging from 0.003 to 0.067 nM. Its favorable pharmacokinetic profile has been demonstrated in preclinical studies using a rhesus monkey model, highlighting its potential utility in HCV research and therapeutic development.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1613081-64-3
Applications HCV NS5A Inhibitor
Formula C49H55FN10O7S
Molecular Weight 947.09
Synonyms MK-8408
SMILES
FC1=C2C3=CC4=CC(C5=CN=C([C@H](CCC6)N6C([C@H](C(C)C)NC(OC)=O)=O)N5)=CC=C4N3[C@H](C7=CN=C(C8CC8)S7)OC2=CC(C9=CN=C([C@H](CCC%10)N%10C([C@H](C(C)C)NC(OC)=O)=O)N9)=C1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...